Clinical trial
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in…
NCT00108290 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00108290 |
|---|---|
| Title | Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer |
| Official title | Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Chemotherapy |
| Start date | Apr 1, 2004 |
| Completion | Mar 1, 2007 |
| First posted | Apr 15, 2005 |
| Last update posted | Apr 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: